Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 5, Pages e0125366
Publisher
Public Library of Science (PLoS)
Online
2015-05-09
DOI
10.1371/journal.pone.0125366
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects
- (2013) X.-H. Zhang et al. CELL CALCIUM
- Catecholaminergic polymorphic ventricular tachycardia: from bench to bedside
- (2013) Christian van der Werf et al. HEART
- Executive Summary: HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes
- (2013) Silvia G. Priori et al. HEART RHYTHM
- Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia
- (2013) Asaad Khoury et al. HEART RHYTHM
- CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia
- (2013) E Di Pasquale et al. Cell Death & Disease
- Catecholaminergic Polymorphic Ventricular Tachycardia
- (2012) Antoine Leenhardt et al. Circulation-Arrhythmia and Electrophysiology
- Modeling of Catecholaminergic Polymorphic Ventricular Tachycardia With Patient-Specific Human-Induced Pluripotent Stem Cells
- (2012) Ilanit Itzhaki et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Reveals Early and Delayed Afterdepolarizations
- (2012) Kirsi Kujala et al. PLoS One
- In vitro Modeling of Ryanodine Receptor 2 Dysfunction Using Human Induced Pluripotent Stem Cells
- (2011) Azra Fatima et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Mutation-Linked Defective Interdomain Interactions Within Ryanodine Receptor Cause Aberrant Ca 2+ Release Leading to Catecholaminergic Polymorphic Ventricular Tachycardia
- (2011) Takeshi Suetomi et al. CIRCULATION
- Inherited Dysfunction of Sarcoplasmic Reticulum Ca 2+ Handling and Arrhythmogenesis
- (2011) Silvia G. Priori et al. CIRCULATION RESEARCH
- Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
- (2011) A. L. Lahti et al. Disease Models & Mechanisms
- Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia
- (2011) Christian B. Jung et al. EMBO Molecular Medicine
- Localization of the Dantrolene-binding Sequence near the FK506-binding Protein-binding Site in the Three-dimensional Structure of the Ryanodine Receptor
- (2011) Ruiwu Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Companies compete over mutation-specific melanoma drugs
- (2011) Cassandra Willyard NATURE MEDICINE
- The Deletion of Exon 3 in the Cardiac Ryanodine Receptor Is Rescued by β Strand Switching
- (2011) Paolo A. Lobo et al. STRUCTURE
- Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction
- (2010) Xiaojuan Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca2+ release in heart failure
- (2010) Makoto Ono et al. CARDIOVASCULAR RESEARCH
- Dantrolene, a Therapeutic Agent for Malignant Hyperthermia, Inhibits Catecholaminergic Polymorphic Ventricular Tachycardia in a RyR2R2474S/+ Knock-In Mouse Model
- (2010) Shigeki Kobayashi et al. CIRCULATION JOURNAL
- Catecholaminergic Polymorphic Ventricular Tachycardia Is Caused by Mutation-Linked Defective Conformational Regulation of the Ryanodine Receptor
- (2010) Hitoshi Uchinoumi et al. CIRCULATION RESEARCH
- Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia
- (2009) Annukka Marjamaa et al. BMC Medical Genetics
- Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia
- (2009) Meiso Hayashi et al. CIRCULATION
- Dantrolene, a Therapeutic Agent for Malignant Hyperthermia, Markedly Improves the Function of Failing Cardiomyocytes by Stabilizing Interdomain Interactions Within the Ryanodine Receptor
- (2009) Shigeki Kobayashi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
- (2009) Hiroshi Watanabe et al. NATURE MEDICINE
- Left Cardiac Sympathetic Denervation for Catecholaminergic Polymorphic Ventricular Tachycardia
- (2008) Arthur A.M. Wilde et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started